BioWorld MedTech

July 9, 2018

Implandata eyes European launch of intraocular pressure sensor

LONDON – Implandata Ophthalmic Products GmbH is gearing up for the European launch of its Eyemate implantable intraocular pressure sensor, as it nears the second closing of a €8 million (US$9.3 million) series C round. Read More

Quantum raises $50M in series A to develop robotic liver cancer treatment

ICD implant rates study says docs eased up after DoJ action

Mount Sinai researchers discover microRNA activity biomarkers in bladder cancer

Toronto lab develops system to eliminate HCV in donated lungs

Financings

Regulatory front

Product briefs

BioWorld MedTech stock report for public med-tech companies

BioWorld MedTech's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 9, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Many US tariffs paused, pharma warned, EU put on notice

BioWorld

The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...